Van Hulzen Asset Management’s Boston Scientific BSX Stock Holding History

Van Hulzen Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-223	Closed	-$19.9K	–	406
2024 Q4	$19.9K	Buy	+223	New	+$19.6K	﹤0.01%	678
2019 Q3	–	Sell	-7,833	Closed	-$337K	–	268
2019 Q2	$337K	Buy	7,833 +2,608	+50%	+$100K	0.07%	184
2019 Q1	$201K	Buy	+5,225	New	+$200K	0.05%	225

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Van Hulzen Asset Management's BSX Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 223 shares — an estimated $19.9K sold.

Van Hulzen Asset Management first reported a position in BSX in Q1 2019 and held it in 3 quarters. The position peaked at $337K in Q2 2019. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Van Hulzen Asset Management reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Van Hulzen Asset Management sold 223 Boston Scientific shares in Q1 2025, an estimated $19.9K.
Van Hulzen Asset Management first reported a position in Boston Scientific in Q1 2019 and held it in 3 quarters.
Van Hulzen Asset Management's Boston Scientific position peaked at $337K in Q2 2019.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.